Product Information
ARIPIPRAZOLE 2 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.1146 per EA under NDC 60687015721. Its NADAC has been published 572 times since Oct 21, 2015.
FDA first approved this application on Apr 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
American Health PackagingNDC
60687015721
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205064FDA Approved
4/28/2015
TE Code
AB
On Market Since
6/5/2015
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 2 MG TABLET has been published 572 times since Oct 21, 2015, and over the history we have for it it has declined 99.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1146 per EA |
|---|---|
| All-time high | $13.7106 (Nov 11, 2015) |
| All-time low | $0.1014 (Nov 20, 2024) |
| 52-week high | $0.1246 |
| 52-week low | $0.1026 |
| Median price | $0.1604 |
| Average price | $0.9914 |
| Largest weekly change | +33.3% (Aug 21, 2024) |
| Weeks tracked | 572 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 2 MG TABLET, manufactured by American Health Packaging, is $0.1146 per EA (NDC 60687015721), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 2 MG TABLET has declined 99.2%. It has been tracked across 572 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 2 MG TABLET?
Since Oct 21, 2015, the NADAC for ARIPIPRAZOLE 2 MG TABLET has ranged from a low of $0.1014 (Nov 20, 2024) to a high of $13.7106 (Nov 11, 2015), with a median of $0.1604 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 2 MG TABLET?
15 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 2 MG TABLET?
ARIPIPRAZOLE 2 MG TABLET (NDC 60687015721) is labeled by American Health Packaging, and CMS classifies it as a generic product.